SCHEDULE: Squadron Capital Sells OrthoPediatrics Shares

Squadron Capital LLC, a significant holder, has disclosed the sale of over 324,000 shares of OrthoPediatrics Corp. common stock in recent transactions.

Summary

• This filing is an amendment to a Schedule 13D, reporting changes in beneficial ownership of OrthoPediatrics Corp. common stock.
• Squadron Capital LLC (SC LLC) directly holds 6,201,764 shares, representing 23.8% of the outstanding common stock.
• Jennifer N. Pritzker and David R. Pelizzon manage SC LLC's voting and investment decisions.
• David R. Pelizzon also directly holds 44,384 shares, including restricted stock.
• Jennifer N. Pritzker directly and/or jointly holds 10,900 shares and has indirect beneficial ownership of additional shares through various entities and her spouse.
• Squadron Capital Holdings LLC (SCH LLC) is the controlling member of SC LLC.
• On September 2, 2026, SC LLC sold 22,500 shares at an average price of $23.35.
• On September 10, 2026, SC LLC sold 302,369 shares at an average price of $21.01.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, primarily due to the significant sale of shares by a major holder, which could indicate a lack of confidence or a need for capital elsewhere, despite the stated reasons.

Positives

• The filing provides transparency regarding significant shareholdings and transactions.
• The stated reason for the sales is to provide capital for other portfolio businesses, suggesting a strategic reallocation of resources.

Negatives

• A substantial number of shares (324,869) were sold by Squadron Capital LLC, a major beneficial owner.
• The average selling price of $21.01 on September 10, 2026, is lower than the $23.35 average price on September 2, 2026, and may be below recent trading prices.
• The reduction in beneficial ownership by a key entity could be interpreted negatively by the market.

Risks

• The sale of a significant block of shares by a major holder could signal a lack of confidence in future price appreciation.
• The need to raise capital for other portfolio businesses might indicate financial pressures or a strategic shift away from OrthoPediatrics Corp.

Future Outlook

No specific forward-looking statements or guidance from OrthoPediatrics Corp. are included in this amendment. The outlook is inferred from the actions of Squadron Capital LLC.

Management Comments

• Sales were undertaken by SC LLC to provide additional capital for its other portfolio businesses.

Industry Context

StockSavvy.ai notes that significant share sales by large institutional investors can sometimes precede or coincide with broader market shifts or company-specific challenges within the medical device sector.

Stakeholder Impact

• Shareholders may react to the significant sale of shares by a major holder, potentially impacting stock price.
• Creditors or other portfolio businesses of Squadron Capital LLC may benefit from the capital infusion.

Next Steps

• Monitoring future filings from Squadron Capital LLC and OrthoPediatrics Corp. for further insights into ownership and company performance.

Key Dates

Recommendation

The filing indicates a significant sale of shares by a major beneficial owner, which is a negative signal. However, the stated reason for the sale is to reallocate capital to other portfolio businesses, which is a neutral to potentially positive strategic move for Squadron Capital. Without further information on OrthoPediatrics Corp.'s performance or future prospects, a 'hold' recommendation is prudent, awaiting more clarity.

Keywords

OrthoPediatrics Corp., Schedule 13D, Beneficial Ownership, Shareholder, Stock Sale, Squadron Capital LLC, Investment Management